Back to Solutions
Global Intelligence

Global Intelligence

Real-time global pharmaceutical intelligence tracking drug development, market dynamics, and competitive landscape across worldwide markets.

190+
Countries Covered
10+
Data Sources
500+
Companies Tracked
24/7
Real-Time Updates

Comprehensive Global Coverage

Advanced intelligence capabilities covering every aspect of global pharmaceutical development and market dynamics.

Worldwide Drug Development

Track pharmaceutical development across 190+ countries with real-time updates on clinical trials, regulatory approvals, and market launches.

  • • Global clinical trial tracking
  • • Regulatory approval monitoring
  • • Market launch intelligence
  • • Cross-border development insights

Market Dynamics Analysis

Analyze global market trends, pricing strategies, and competitive positioning across different regions and therapeutic areas.

  • • Regional market sizing
  • • Pricing benchmarking
  • • Market share analysis
  • • Growth opportunity identification

Competitive Intelligence

Monitor competitor activities, pipeline developments, and strategic moves across global markets with AI-powered insights.

  • • Competitor pipeline tracking
  • • Strategic partnership monitoring
  • • Market entry analysis
  • • Competitive positioning insights

Intelligence Process

01

Data Aggregation

Collect data from 10+ authoritative sources including FDA, EMA, ClinicalTrials.gov, and more.

02

AI Analysis

AI-powered analysis of global drug development, market dynamics, and competitive landscape.

03

Regional Insights

Generate localized insights for each region with regulatory, market, and competitive context.

04

Strategic Recommendations

Deliver actionable recommendations for portfolio strategy, market entry, and competitive positioning.

Key Capabilities

190+ Countries
Global Coverage
Real-Time
Market Analysis
Predictive
AI Insights
Localized
Regional Intelligence

Regional Intelligence Coverage

Comprehensive coverage across all major pharmaceutical markets with localized insights and analysis.

🇺🇸

North America

US, Canada, Mexico - FDA, Health Canada, and regulatory tracking

🇪🇺

Europe

EMA, national agencies, and comprehensive EU market intelligence

🇯🇵

Asia Pacific

Japan, China, India, Australia and emerging APAC markets

🌍

Emerging Markets

Latin America, Middle East, Africa growth opportunities

Real-World Applications

How pharmaceutical companies use global intelligence to drive strategic decisions.

1

Global Portfolio Strategy

Optimize drug development portfolios with insights into global market opportunities, competitive landscapes, and regulatory pathways across regions.

2

Market Entry Planning

Identify optimal market entry strategies with comprehensive analysis of regulatory requirements, pricing dynamics, and competitive positioning.

3

Competitive Benchmarking

Benchmark performance against global competitors with real-time tracking of their development pipelines, market strategies, and commercial success.

Comprehensive Data Sources

Powered by 10+ authoritative data sources providing real-time global pharmaceutical intelligence.

Regulatory & Clinical

  • • FDA, EMA, PMDA databases
  • • ClinicalTrials.gov
  • • National regulatory agencies
  • • Clinical trial registries

Market & Commercial

  • • Market research reports
  • • Pricing databases
  • • Sales and prescription data
  • • Market share analytics

Scientific & Academic

  • • PubMed and research databases
  • • Scientific publications
  • • Conference proceedings
  • • Patent databases

Frequently Asked Questions

What is global pharmaceutical intelligence?

Global pharmaceutical intelligence is a comprehensive platform that tracks drug development, market dynamics, and competitive landscapes across worldwide markets. It provides real-time insights into clinical trials, regulatory approvals, market launches, and competitive positioning across 190+ countries.

How many countries do you cover?

We cover 190+ countries across all major pharmaceutical markets including North America (FDA, Health Canada), Europe (EMA, national agencies), Asia Pacific (Japan, China, India, Australia), and emerging markets in Latin America, Middle East, and Africa.

What data sources power the platform?

Our platform is powered by 10+ authoritative data sources including FDA, EMA, PMDA databases, ClinicalTrials.gov, national regulatory agencies, market research reports, pricing databases, PubMed, scientific publications, conference proceedings, and patent databases.

How can global intelligence improve portfolio strategy?

Global intelligence helps optimize drug development portfolios by providing insights into global market opportunities, competitive landscapes, and regulatory pathways across regions. It enables data-driven decisions on market entry, resource allocation, and competitive positioning.

Transform Your Global Strategy

Gain comprehensive global pharmaceutical intelligence to drive strategic decisions and competitive advantage.